GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Tecan Group TECN.SW · CHF

Health Care · SIX · 🇨🇭 Switzerland

Compare

258.20

+0.23%

Close of 9 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CHF, from our data supplier.

FY2025

Revenue

CHF 882.5m

FY2016FY2025

Net income

−CHF 110.7m

FY2016FY2025

Free cash flow

CHF 102.7m

FY2016FY2025

Shareholders' equity

CHF 1.15bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCHF 882.5mCHF 934.3mCHF 1.07bnCHF 1.14bnCHF 946.6mCHF 730.9mCHF 636.8mCHF 593.8mCHF 548.6mCHF 506.2m
Gross profitCHF 280.2mCHF 320.6mCHF 390.5mCHF 405.3mCHF 388.0mCHF 339.9mCHF 282.7mCHF 278.0mCHF 264.8mCHF 239.4m
Research and developmentCHF 68.6mCHF 68.4mCHF 70.0mCHF 61.0mCHF 59.8mCHF 48.6mCHF 48.9mCHF 63.7mCHF 62.3mCHF 55.0m
Operating incomeCHF 25.2mCHF 75.6mCHF 136.0mCHF 146.0mCHF 141.1mCHF 123.0mCHF 88.9mCHF 87.4mCHF 81.8mCHF 68.7m
Net income−CHF 110.7mCHF 67.7mCHF 132.1mCHF 121.1mCHF 121.7mCHF 103.7mCHF 73.2mCHF 70.7mCHF 66.5mCHF 54.5m
Diluted earnings per share-8.735.3010.289.449.428.676.125.955.604.67

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCHF 1.70bnCHF 2.12bnCHF 2.07bnCHF 2.16bnCHF 2.04bnCHF 1.13bnCHF 939.8mCHF 857.7mCHF 804.0mCHF 736.2m
Cash and short-term investmentsCHF 311.4mCHF 406.0mCHF 366.4mCHF 293.2mCHF 241.9mCHF 470.9mCHF 316.8mCHF 296.8mCHF 309.4mCHF 246.7m
Total liabilitiesCHF 546.6mCHF 686.2mCHF 725.1mCHF 776.4mCHF 800.3mCHF 380.5mCHF 280.7mCHF 245.3mCHF 253.8mCHF 249.1m
DebtCHF 218.3mCHF 321.3mCHF 316.1mCHF 307.7mCHF 313.7mCHF 38.7mCHF 47.9mCHF 2.3mCHF 5.6mCHF 1.8m
Shareholders' equityCHF 1.15bnCHF 1.44bnCHF 1.35bnCHF 1.36bnCHF 1.22bnCHF 733.7mCHF 659.1mCHF 612.4mCHF 550.1mCHF 487.1m
Shares outstanding13m13m13m13m13m12m12m12m12m12m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCHF 138.0mCHF 148.5mCHF 160.6mCHF 128.3mCHF 169.9mCHF 208.3mCHF 98.8mCHF 92.7mCHF 99.4mCHF 118.8m
Capital spending−CHF 35.3m−CHF 30.7m−CHF 34.9m−CHF 36.2m−CHF 39.7m−CHF 41.3m−CHF 23.9m−CHF 11.8m−CHF 8.1m−CHF 6.8m
Free cash flowCHF 102.7mCHF 117.9mCHF 125.6mCHF 92.0mCHF 130.1mCHF 167.0mCHF 74.9mCHF 80.9mCHF 91.3mCHF 112.0m
Dividends paid−CHF 38.0m−CHF 38.3m−CHF 37.0m−CHF 35.6m−CHF 27.6m−CHF 26.2m−CHF 24.8m−CHF 23.5m−CHF 20.3m−CHF 20.1m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Mar 2023
RevenueCHF 427.5mCHF 443.0mCHF 439.5mCHF 467.1mCHF 467.2mCHF 532.9mCHF 541.5mCHF 270.8m
Gross profitCHF 144.9mCHF 151.6mCHF 159.3mCHF 159.8mCHF 160.8mCHF 185.9mCHF 204.6mCHF 102.3m
Operating incomeCHF 18.4mCHF 21.6mCHF 23.1mCHF 45.9mCHF 23.2mCHF 67.6mCHF 61.5mCHF 31.3m
Net incomeCHF 12.3m−CHF 128.6mCHF 17.9mCHF 45.2mCHF 22.5mCHF 78.9mCHF 53.2mCHF 26.6m
Diluted earnings per share0.99-10.151.413.541.766.144.142.08
Cash from operationsCHF 17.0mCHF 78.0mCHF 61.0mCHF 106.0mCHF 43.0mCHF 80.0mCHF 83.0m—
Capital spending−CHF 5.0m−CHF 30.0m−CHF 5.0m−CHF 11.0m−CHF 3.0m−CHF 16.0m−CHF 18.0m—
Free cash flowCHF 12.0mCHF 48.0mCHF 56.0mCHF 95.0mCHF 40.0mCHF 64.0mCHF 65.0m—
Total assetsCHF 1.65bnCHF 1.70bnCHF 1.94bnCHF 2.12bnCHF 2.12bnCHF 2.07bnCHF 2.08bn—
Cash and short-term investmentsCHF 224.6mCHF 311.4mCHF 397.0mCHF 406.0mCHF 343.8mCHF 366.4mCHF 314.3m—
DebtCHF 20.2mCHF 229.0mCHF 322.0mCHF 321.3mCHF 315.5mCHF 316.7mCHF 300.0m—
Shareholders' equityCHF 1.12bnCHF 1.15bnCHF 1.28bnCHF 1.44bnCHF 1.41bnCHF 1.35bnCHF 1.34bn—

Financial ratios

Data as of 2 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin31.8%34.3%36.3%35.4%41.0%46.5%
Operating margin2.9%8.7%12.5%12.6%15.0%16.4%
Net margin-12.5%7.2%12.3%10.6%12.9%14.2%
Return on equity-9.6%4.7%9.8%8.9%9.9%14.1%
Return on assets-6.5%3.2%6.4%5.6%6.0%9.2%
Free cash flow yield5.5%5.7%6.2%5.2%6.6%8.5%
Revenue growth-5.5%-13.0%-6.1%20.9%29.5%14.8%
Earnings growth-263.5%-48.8%9.0%-0.4%17.3%41.7%
Current ratio2.46x1.61x2.86x2.39x2.19x3.46x
Debt to equity0.14x0.18x0.19x0.19x0.21x0.02x
Equity ratio67.8%67.7%65.0%62.8%59.9%64.9%
Interest coverage7.60x29.83x101.19x97.43x33.48x90.77x
R&D as a share of sales7.8%7.3%6.5%5.3%6.3%6.7%
Buybacks as a share of market value0.7%0.7%-0.1%0.7%-8.0%-0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-8.3%3.8%7.2%
Operating income-44.3%-27.1%-9.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin33.1%34.6%37.2%40.3%
Operating margin5.5%9.5%11.3%12.3%
Net margin-2.4%5.2%7.6%9.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-14.738.233.443.759.050.044.532.136.234.0
Price to sales1.82.84.14.67.67.15.13.84.43.7

Dividends and splits

Per share, in the currency the company pays

Paid for 29 years. Last went ex-dividend on 17 Apr 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year3.001.501.501.451.401.151.102.10
  • 1-to-1 reverse split · 24 Aug 2005
  • 1-to-1 reverse split · 1 Oct 2004
  • 100000-to-1 reverse split · 4 May 2001
  • 1-for-0.1 split · 3 Jun 1999

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.